You just read:

Viking Therapeutics Presents Positive Proof-of-Concept Data for VK0214 in In Vivo Model of X-Linked Adrenoleukodystrophy (X-ALD) at the 86th Annual Meeting of the American Thyroid Association

News provided by

Viking Therapeutics, Inc.

Sep 26, 2016, 07:05 ET